Prognostic Utility of Hematological Inflammatory Markers in Stratifying Cancer Risk in Laryngeal Premalignant Lesions. Puente-Verez M, Martin-Gonzalez R, Pedregal-Mallo D, Garcia-Pedrero JM, et al. Otolaryngol Head Neck Surg 2026;174:1562-1571.

Read + Share

Amedeo Smart

Independent Medical Education

Puente-Verez M, Martin-Gonzalez R, Pedregal-Mallo D, Garcia-Pedrero JM, et al. Prognostic Utility of Hematological Inflammatory Markers in Stratifying Cancer Risk in Laryngeal Premalignant Lesions. Otolaryngol Head Neck Surg 2026;174:1562-1571.
PMID: 41940701